Wainfan E, Moller M L, Maschio F A, Balis M E
Cancer Res. 1975 Oct;35(10):2830-5.
We have confirmed the finding by Rajalakshmi that transfer RNA (tRNA) from livers of ethionine-treated rats can act as a substrate for homologous tRNA-methylating enzymes in vitro. This methyl-deficient tRNA from liver can be methylated in vitro by enzymes from normal or ethionine-treated rats. The in vitro inhibition of tRNA methylation that follows ethionine treatment can be at least partially relieved in vitro. The liver extracts from ethionine-treated animals contained a low-molecular-weight inhibitor of tRNA methylation. Dialysis of enzyme preparations from ethionine-treated, but not control, rats resulted in large increases in tRNA methylase activity, with either Escherichia coli or homologous tRNA's as substrate. Furthermore, the tRNA methylase activity of control rat liver enzyme extracts was greatly depressed by dialysate from liver homogenates of ethionine-treated rats. After 5 days of ethionine administration the liver tRNA methylase activities were significantly higher than those of control preparations despite the continued presence of the dialyzable inhibitor(s). The liver tRNA's from these animals were poorer methyl acceptors than those from 3-day-treated rats, although still better than tRNA's from untreated rats. These observations have been interpreted to indicate that ethionine causes the accumulation in the liver of inhibitors of tRNA methylation. Early in the course of ethionine administration, methyl-deficient tRNA can be isolated. When the period of ethionine treatment is extended, the organism attempts to maintain homeostasis by production of increased amounts of tRNA-methylating enzymes. The increased quantities of these enzymes are able to overcome, at least partially, the effects of the inhibitors and to decrease the extent to which methyl-deficient tRNA is produced.
我们已经证实了拉贾拉克希米的发现,即从乙硫氨酸处理过的大鼠肝脏中提取的转运RNA(tRNA)在体外可作为同源tRNA甲基化酶的底物。这种来自肝脏的甲基缺乏型tRNA在体外可被正常大鼠或乙硫氨酸处理过的大鼠的酶甲基化。乙硫氨酸处理后对tRNA甲基化的体外抑制作用至少可在体外部分缓解。乙硫氨酸处理过的动物的肝脏提取物含有一种低分子量的tRNA甲基化抑制剂。用乙硫氨酸处理过但非对照的大鼠的酶制剂进行透析,会导致以大肠杆菌或同源tRNA为底物时tRNA甲基化酶活性大幅增加。此外,乙硫氨酸处理过的大鼠肝脏匀浆的透析液会极大地抑制对照大鼠肝脏酶提取物的tRNA甲基化酶活性。在给予乙硫氨酸5天后,尽管仍存在可透析的抑制剂,但肝脏tRNA甲基化酶活性显著高于对照制剂。这些动物肝脏的tRNA作为甲基受体比3天处理组大鼠的tRNA差,不过仍比未处理大鼠的tRNA好。这些观察结果被解释为表明乙硫氨酸导致肝脏中tRNA甲基化抑制剂的积累。在给予乙硫氨酸的早期,可以分离出甲基缺乏型tRNA。当乙硫氨酸处理时间延长时,机体试图通过产生更多的tRNA甲基化酶来维持体内平衡。这些酶数量的增加能够至少部分克服抑制剂的作用,并减少甲基缺乏型tRNA的产生程度。